Real-world efficacy of elbasvir/grazoprevir in HCV GT1 infected diabetics: results from the German Hepatitis C Registry

J Schattenberg,A Stoehr,M Cornberg,H Klinker,R Heyne,C John,KG Simon,M Bilzer,V Guenther,V Witte,S Zeuzem

Zeitschrift für Gastroenterologie36. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber（2020）

引用 0|浏览3

暂无评分

摘要

Type 2 diabetes mellitus is a well-described extrahepatic manifestation of HCV infection. Here, we investigated the real-world effectiveness of EBR/GZR in patients (pts) without and with diabetes in a large GT1 cohort of the German Hepatitis C Registry (DHC-R). In addition, we evaluated the impact of HCV treatment on diabetes disease progression.

查看译文

关键词

hcv gt1,elbasvir/grazoprevir,infected diabetics,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要